# Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease

> **NCT06161766** · — · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 490 (actual)

## Conditions studied

- Liver Cirrhosis
- Hepato-Renal Syndrome
- Chronic Kidney Diseases

## Interventions

- **DRUG:** terlipressin or noradrenalin plus albumin

## Key facts

- **NCT ID:** NCT06161766
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-03
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 490 (ACTUAL)
- **Last updated:** 2025-12-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06161766

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06161766, "Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT06161766. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*